Literature DB >> 17188846

Prevalence and demography of transsexualism in Belgium.

G De Cuypere1, M Van Hemelrijck, A Michel, B Carael, G Heylens, R Rubens, P Hoebeke, S Monstrey.   

Abstract

AIM: The Belgian medical world has acknowledged the diagnosis of transsexualism and accepted Sex Reassignment Surgery (SRS) as one of the steps in the treatment of choice since 1985. This prevalence and demographic study analyses data on all Belgian individuals who have undergone SRS since that year.
METHODS: All (188) plastic surgeons as well as all gender teams (Antwerp, Bruges, Ghent, and Liège) in Belgium were sent demographic questionnaires to be completed for each of their transsexual patients.
RESULTS: The results show an overall prevalence of 1:12,900 for male-to-female and 1:33,800 for female-to-male transsexuals in Belgium. In Wallonia (the French-speaking region of Belgium) the prevalence is significantly lower than in Flanders (the Dutch-speaking region) and in Brussels (the bilingual capital region). In the total Belgian population the male/female sex ratio is 2.43:1, again with a substantial difference between Wallonia on the one hand and Flanders on the other. DISCUSSION AND
CONCLUSION: While in Flanders and in Brussels the prevalence is comparable to that in other Western European countries, in Wallonia it is markedly lower. Transsexualism in Wallonia appears to be socially less acceptable: persons suffering from gender dysphoria in that part of Belgium encounter more problems accessing gender clinics and receiving treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17188846     DOI: 10.1016/j.eurpsy.2006.10.002

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  33 in total

1.  Brain activation-based sexual orientation in female-to-male transsexuals.

Authors:  T-H Kim; G-W Kim; S-K Kim; G-W Jeong
Journal:  Int J Impot Res       Date:  2015-11-19       Impact factor: 2.896

2.  Prevalence of gender identity disorder and suicide risk among transgender veterans utilizing veterans health administration care.

Authors:  John R Blosnich; George R Brown; Jillian C Shipherd Phd; Michael Kauth; Rebecca I Piegari; Robert M Bossarte
Journal:  Am J Public Health       Date:  2013-08-15       Impact factor: 9.308

3.  Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples.

Authors:  Esther L Meerwijk; Jae M Sevelius
Journal:  Am J Public Health       Date:  2017-02       Impact factor: 9.308

4.  Sperm cryopreservation of transgender individuals: trends and findings in the past decade.

Authors:  K Li; D Rodriguez; J S Gabrielsen; G M Centola; C Tanrikut
Journal:  Andrology       Date:  2018-08-09       Impact factor: 3.842

Review 5.  Penile fracture and penile reconstruction.

Authors:  Giulio Garaffa; Amr Abdel Raheem; David John Ralph
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

6.  Satisfaction with male-to-female gender reassignment surgery.

Authors:  Jochen Hess; Roberto Rossi Neto; Leo Panic; Herbert Rübben; Wolfgang Senf
Journal:  Dtsch Arztebl Int       Date:  2014-11-21       Impact factor: 5.594

7.  Regional gray matter variation in male-to-female transsexualism.

Authors:  Eileen Luders; Francisco J Sánchez; Christian Gaser; Arthur W Toga; Katherine L Narr; Liberty S Hamilton; Eric Vilain
Journal:  Neuroimage       Date:  2009-03-31       Impact factor: 6.556

8.  Collective Self-Esteem as a Coping Resource for Male-to-Female Transsexuals.

Authors:  Francisco J Sánchez; Eric Vilain
Journal:  J Couns Psychol       Date:  2009-01-01

Review 9.  Prevalence of Transgender Depends on the "Case" Definition: A Systematic Review.

Authors:  Lindsay Collin; Sari L Reisner; Vin Tangpricha; Michael Goodman
Journal:  J Sex Med       Date:  2016-03-25       Impact factor: 3.802

10.  Combined type IIIB with bilateral type I thyroplasty for pitch lowering with maintenance of vocal fold tension.

Authors:  Matthew R Hoffman; Erin E Devine; Marc Remacle; Charles N Ford; Elizabeth Wadium; Jack J Jiang
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-16       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.